Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease

doi:10.3748/wjg.v25.i34.5105

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 34

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11946)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-12) series.

Item

Count

PDF

856

WORD

254

HTML

8509

Figures (1-4)

273

Tables (1-12)

195

Sum=10087

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

652

Download

1207

Sum=1859

Sep 14, 2019 (publication date) through May 5, 2024

Times Cited of This Article

Times Cited (56)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Sep 14, 2019; 25(34): 5105-5119
Published online Sep 14, 2019. doi: 10.3748/wjg.v25.i34.5105

Table 9 Intestinal sIgA levels (mean ± SD)

Group	n	sIgA (μg/mg)
Control	8	19.80 ± 2.25
Model	8	11.39 ± 1.81^b
PH	8	17.06 ± 2.92^a^d
CHM	8	12.78 ± 2.36^bf

^aP < 0.05,

^bP < 0.01 vs control group;

^dP < 0.01 vs model group; ^efP < 0.01 vs PH group. sIgA: Secreted immunoglobulin A; PH: Pioglitazone hydrochloride; CHM: Chinese herbal medicine.

Citation: Yang JM, Sun Y, Wang M, Zhang XL, Zhang SJ, Gao YS, Chen L, Wu MY, Zhou L, Zhou YM, Wang Y, Zheng FJ, Li YH. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease. World J Gastroenterol 2019; 25(34): 5105-5119
URL: https://www.wjgnet.com/1007-9327/full/v25/i34/5105.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i34.5105